Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$20.79 USD
-0.56 (-2.62%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.79 0.00 (0.00%) 7:28 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.49 |
EPS Last Quarter | 0.56 |
Last EPS Surprise | 33.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.92 |
Next Year | 2.26 |
EPS (TTM) | 1.23 |
P/E (F1) | 11.13 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 122.97M | 128.41M | 472.59M | 557.65M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 127.78M | 132.14M | 474.41M | 585.40M |
Low Estimate | 119.50M | 123.10M | 471.27M | 537.28M |
Year ago Sales | 102.69M | 110.57M | 398.20M | 472.59M |
Year over Year Growth Est. | 19.75% | 16.13% | 18.68% | 18.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.49 | 0.52 | 1.92 | 2.26 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | NA | 0.50 | 1.91 | 2.09 |
High Estimate | 0.51 | 0.56 | 1.99 | 2.57 |
Low Estimate | 0.47 | 0.50 | 1.77 | 2.09 |
Year ago EPS | -0.24 | 0.53 | 1.96 | 1.92 |
Year over Year Growth Est. | 304.17% | -1.89% | -2.04% | 18.02% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 3 | 1 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 0 | 2 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.49 | 0.52 | 1.92 | 2.26 |
7 Days Ago | 0.49 | 0.52 | 1.92 | 2.26 |
30 Days Ago | 0.49 | 0.53 | 1.89 | 2.26 |
60 Days Ago | 0.48 | 0.53 | 1.75 | 2.09 |
90 Days Ago | 0.48 | 0.53 | 1.74 | 2.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.49 | 0.50 | 1.91 | 2.09 |
Zacks Consensus Estimate | 0.49 | 0.52 | 1.92 | 2.26 |
Earnings ESP | 0.00% | -4.31% | -0.42% | -7.69% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.56 | 0.38 | 0.53 | -0.24 | NA |
Estimate | 0.42 | 0.34 | 0.48 | -0.24 | NA |
Difference | 0.14 | 0.04 | 0.05 | 0.00 | 0.06 |
Surprise | 33.33% | 11.76% | 10.42% | 0.00% | 13.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more